SIRT1 and Guillain-Barre syndrome: GS-Rd improves vascular damage caused by diabetes by activating AMPK and promoting the expression of SIRT1 and has a good protective effect on blood vessels (Tang et al., 2022); GS-Rd performs a protective role in EAN (Experimental autoimmune neuritis) nerve injury by modulating monocyte conversion and might be a novel preventive intervention for GBS (Guillain-Barre Syndrome) (Ren et al., 2021).